Phenylketonuria management from an European perspective: a commentary.
Phenylketonuria is discussed from an European perspective, addressing the need of common definitions of terms commonly used, the need of a world-wide guideline on the diagnosis and treatment of phenylketonuria, the differences between existing European guidelines, and day-to-day care, further directives for the near future, and changing the concept from compliance to concordance, in which patients have a more clearly defined responsibility.
van Spronsen
Francjan J
FJ
Beatrix Children's Hospital, University Medical Center of Groningen, University of Groningen, Groningen, The Netherlands. f.j.van.spronsen@bkk.umcg.nl
D000293:Adolescent; D000328:Adult; D002648:Child; D005060:Europe; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D010349:Patient Compliance; D010649:Phenylalanine / Q000097:blood; D010651:Phenylalanine Hydroxylase / Q000172:deficiency; D010661:Phenylketonurias / Q000191:economics / Q000523:psychology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'
D010649:Phenylalanine; D010651:Phenylalanine Hydroxylase